HK Stock MarketDetailed Quotes

02898 SUNHO BIO-B

Watchlist
  • 4.400
  • +0.020+0.46%
Market Closed Dec 5 16:08 CST
689.33MMarket Cap-5866P/E (TTM)

About SUNHO BIO-B Company

We are a biopharmaceutical company dedicated to the discovery, development and commercialization of first-of-it/best-in-class biologics to regulate the immune microenvironment by directly regulating the innate and adaptive immune systems. Using our deep understanding of immunology, we have developed various types of immunotherapy, including antibody cytokines for cancer and autoimmune diseases. Our relentless commitment to innovation can be seen in our proprietary technology platforms, which include (i) the AIC platform, an expandable platform focused primarily on antibody-cytokine fusion protein development; (ii) the ADCC enhanced antibody platform (“AEA platform”), a FUT8 knockout cell line built to enhance the cytotoxicity of antibodies; and (iii) the enhanced natural immune cell polyantibody platform (“AIM platform”), a platform focused on developing bispecial/polyspecific antibodies based on innate immune stimulants. Our experienced in-house R&D team members come from diverse medical backgrounds and have rich and in-depth knowledge, which is critical to strengthening our R&D capabilities. The functions of our comprehensive R&D team cover drug discovery, in vitro evaluation, pharmacology and pharmacodynamics, protein engineering, process development, and quality analysis.

Company Profile

Symbol02898
Company NameSUNHO BIO-B
ISINKYG8572S1021
Listing DateMay 24, 2024
Issue Price13.50
Shares Offered34.15M share(s)
FoundedMay 14, 2021
Registered AddressCayman Islands
Chairmanfeng zhang
Secretarykaitingxuchunqin huang
Audit InstitutionDeloitte Guan Huang Chen Fang Certified Public Accountants
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficePO Box 309 Ugland House Grand Cayman, KY1-1104 Cayman Islands
Head Office and Principal Place of Business31st Floor, Tower 2, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees124
MarketHong Kong motherboard
Phone(025)85666008
Emailharvest@sunho-bio.com;chenzi@sunho-bio.com
Business Sunho Biologics Inc is a company mainly engaged in biotechnology research and development and production. The company is mainly engaged in the discovery, development and commercialization of biologics to regulate the immune microenvironment by directly regulating the innate and adaptive immune systems. The company has three core products, namely IAH0968, IAP0971, and IAE0972. IAH0968 is an antibody-dependent cell-mediated single antibody with enhanced cytotoxicity. IAP0971 and IAE0972 are both antibody cell hormones.

Company Executives

  • Name
  • Position
  • Salary
  • feng zhang
  • Chairman of the Board, Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
  • --
  • liusong yin
  • CEOs, Executive Director, Chief Scientific Officer
  • --
  • xiaoling jiang
  • VP, Executive Director
  • --
  • rongkui fan
  • Non-executive Directors
  • --
  • xiangrong chen
  • Independent Non-Executive Director, Chairman of the Audit Committee
  • --
  • lan feng
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • --
  • luwen shi
  • Independent Non-Executive Director, Audit Committee Members, Remuneration Committee Members, Nomination Committee Members
  • --
  • chunqin xu
  • Chief Financial Officer, Joint Company Secretary
  • --
  • dongcheng jiang
  • VP
  • --
  • kaiting huang
  • Joint Company Secretary, Authorized Representative
  • --
Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data